The Prescription Information Modernization Act of 2025 would allow pharmaceutical manufacturers to deliver FDA-approved prescribing information to doctors and pharmacists primarily through digital means rather than requiring paper copies. The law would apply to most prescription drugs and biological products, but manufacturers must give healthcare professionals the option to continue receiving paper copies or request them at any time at no extra cost. The Health and Human Services Department has one year from enactment to issue final regulations implementing the change and providing instructions on how providers can obtain paper versions, with the new rules designed to minimize economic burdens on prescribers and pharmacies. The digital-first approach would take effect two years after the law passes or when the implementing regulations are finalized, whichever comes first. Additionally, the FDA must hold a public workshop within two years to gather feedback from stakeholders on optimizing the format and accessibility of prescribing information going forward.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.